Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China
· Delayed Price · Currency is CNY 3.690
+0.010 (0.27%)
Apr 28, 2025, 2:45 PM CST
SHA:600664 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 726.8 | 690.61 | 395.26 | 465.15 | 371.08 | -1,078 | Upgrade
|
| Depreciation & Amortization | 288.23 | 288.23 | 291.58 | 310.39 | 307.54 | 369.75 | Upgrade
|
| Other Amortization | 4.67 | 4.67 | 20.17 | 10.97 | 19.61 | 12.84 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.03 | -1.03 | -1.33 | -161.38 | -210.74 | -14.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 100.16 | 100.16 | 82.8 | 33.59 | 2.19 | 74.72 | Upgrade
|
| Loss (Gain) From Sale of Investments | -12.44 | -12.44 | -4.48 | -20.33 | -0.85 | -35.38 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -26.22 | -1.67 | 10.94 | 28.04 | Upgrade
|
| Other Operating Activities | -205.96 | 24.01 | 157.71 | 150.13 | 144.79 | 317.41 | Upgrade
|
| Change in Accounts Receivable | 118.67 | 118.67 | -94.42 | -237.95 | -613.94 | -569.32 | Upgrade
|
| Change in Inventory | 36.7 | 36.7 | -119.59 | 277.86 | -166.46 | 124.64 | Upgrade
|
| Change in Accounts Payable | -450.37 | -450.37 | 245.21 | -202.97 | -30.11 | 230.34 | Upgrade
|
| Change in Other Net Operating Assets | -0.38 | -0.38 | - | - | - | - | Upgrade
|
| Operating Cash Flow | 598.72 | 792.5 | 949.67 | 622.09 | -162.44 | -728.15 | Upgrade
|
| Operating Cash Flow Growth | 20.65% | -16.55% | 52.66% | - | - | - | Upgrade
|
| Capital Expenditures | -105.96 | -100.81 | -86.54 | -89.65 | -76.7 | -118.21 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.52 | 1.2 | 35.94 | 151.03 | 177.46 | 15.19 | Upgrade
|
| Cash Acquisitions | -0.01 | -0.01 | - | - | - | 0.02 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 1.84 | Upgrade
|
| Other Investing Activities | 0.71 | 0.71 | -156.05 | 10.95 | -9.15 | - | Upgrade
|
| Investing Cash Flow | -101.74 | -98.91 | -206.64 | 72.34 | 91.62 | -101.17 | Upgrade
|
| Long-Term Debt Issued | - | 1,905 | 3,207 | 2,158 | 1,857 | 1,611 | Upgrade
|
| Long-Term Debt Repaid | - | -1,909 | -3,435 | -2,076 | -1,220 | -525.45 | Upgrade
|
| Net Debt Issued (Repaid) | -399.62 | -4.62 | -228.23 | 82.06 | 637.06 | 1,086 | Upgrade
|
| Issuance of Common Stock | - | - | 3.73 | 16.98 | 15.53 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -8.36 | - | - | - | Upgrade
|
| Common Dividends Paid | -51.42 | -47.11 | -44.16 | -54.3 | -61.55 | -24.1 | Upgrade
|
| Other Financing Activities | -71.96 | -73.88 | 424.97 | 129.88 | -197.78 | - | Upgrade
|
| Financing Cash Flow | -523 | -125.61 | 147.94 | 174.62 | 393.26 | 1,061 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.98 | 2.24 | 0.92 | 3.74 | -2.91 | -0.87 | Upgrade
|
| Net Cash Flow | -24.04 | 570.22 | 891.89 | 872.79 | 319.54 | 231.22 | Upgrade
|
| Free Cash Flow | 492.76 | 691.69 | 863.14 | 532.45 | -239.13 | -846.37 | Upgrade
|
| Free Cash Flow Growth | 19.84% | -19.86% | 62.11% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 3.04% | 4.28% | 5.58% | 3.86% | -1.87% | -7.85% | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.28 | 0.35 | 0.21 | -0.10 | -0.34 | Upgrade
|
| Cash Income Tax Paid | 805.36 | 810.92 | 815.72 | 728.98 | 711.43 | 610.93 | Upgrade
|
| Levered Free Cash Flow | 694.77 | 744.92 | 891.87 | 837.21 | 310.96 | -416.28 | Upgrade
|
| Unlevered Free Cash Flow | 694.77 | 744.92 | 927.16 | 890.67 | 376.68 | -379.86 | Upgrade
|
| Change in Net Working Capital | 123.83 | 56.21 | -310.93 | -306.57 | 162.39 | 142.19 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.